Respiratory syncytial virus, an ongoing medical dilemma: an expert commentary on respiratory syncytial virus prophylactic and therapeutic pharmaceuticals currently in clinical trials
about
Risk of nosocomial respiratory syncytial virus infection and effectiveness of control measures to prevent transmission events: a systematic reviewGenetic association of TLR4 Asp299Gly, TLR4 Thr399Ile, and CD14 C-159T polymorphisms with the risk of severe RSV infection: a meta-analysisApproved Antiviral Drugs over the Past 50 YearsDefining the Epidemiology and Burden of Severe Respiratory Syncytial Virus Infection Among Infants and Children in Western CountriesRespiratory Infections in the U.S. Military: Recent Experience and ControlNovel therapies and vaccines against the human respiratory syncytial virus.Coptidis Rhizoma extract inhibits replication of respiratory syncytial virus in vitro and in vivo by inducing antiviral state.Ongoing developments in RSV prophylaxis: a clinician's analysis.Roles of Non-coding RNAs in Respiratory Syncytial Virus (RSV) Infection.Advances in Vaccines to Prevent Viral Respiratory Illnesses in Children.Immunization with Low Doses of Recombinant Postfusion or Prefusion Respiratory Syncytial Virus F Primes for Vaccine-Enhanced Disease in the Cotton Rat Model Independently of the Presence of a Th1-Biasing (GLA-SE) or Th2-Biasing (Alum) Adjuvant.Respiratory syncytial virus elicits enriched CD8+ T lymphocyte responses in lung compared with blood in African green monkeys.Respiratory Syncytial Virus (RSV): Targeting the G Protein Provides a New Approach for an Old Problem.On the relative role of different age groups during epidemics associated with respiratory syncytial virus.Antibody therapies for the prevention and treatment of viral infections.Vaccines for the Paramyxoviruses and Pneumoviruses: Successes, Candidates, and Hurdles.Blocking of opioid receptors in experimental formaline-inactivated respiratory syncytial virus (FI-RSV) immunopathogenesis: from beneficial to harmful impacts.Community-acquired pneumonia in children; the challenges of microbiological diagnosis.Past, Present and Future Approaches to the Prevention and Treatment of Respiratory Syncytial Virus Infection in Children.Nucleosides for the treatment of respiratory RNA virus infections.
P2860
Q26768419-14674375-CF82-41A7-869A-E189E3474BD3Q26768424-A7DFE944-1203-4094-9DDF-E4FED773A55CQ27755387-C227C420-D291-4233-A0DF-2BEB3F90CC93Q28069415-D8FA44FC-6385-41A6-8AC4-7E82DD8B4125Q35763405-99C4A010-A576-4218-90C5-98F98C4B59EEQ38604787-FE7D5004-3561-46FD-B61C-78A49705B38EQ38702032-DEE4C338-C920-4568-90B1-B83D6E194AEBQ39303791-7BFFD1D1-A5DD-472E-B9D9-9FB9A95F30EFQ39395437-7DC3BFD5-C140-4DCE-8CB3-57C2196B7DB7Q40082914-CAA9F1C9-569C-4D2C-B711-9C1E2A68F0FEQ40349822-6519E5F3-D0A5-4C22-9088-E65EECC12BCCQ45325049-79347E7C-659C-4CC6-9B74-24026A8B31EFQ45325102-8B3F4D6A-F8B0-4CB5-BCC9-4AD21FC2B6BBQ45325184-F116C889-B1CB-4A23-9FF0-C00B8DF83A08Q47143843-3BD8B67C-81D7-4D52-A72C-43E95CC01FE3Q47555408-85C0B3E5-D0F1-42C1-AD98-330CA614D2A3Q47562812-0D75C23C-1716-4DB0-A5F3-24E9DE9F806FQ47566059-509174AA-DE42-45D9-9DD9-D5A96D9D0DB1Q50262223-5D9840E8-FE14-4D95-99C3-47DAE05B391BQ52644426-F343D921-8263-4C8D-BD67-B9E4247A7F84
P2860
Respiratory syncytial virus, an ongoing medical dilemma: an expert commentary on respiratory syncytial virus prophylactic and therapeutic pharmaceuticals currently in clinical trials
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Respiratory syncytial virus, a ...... s currently in clinical trials
@ast
Respiratory syncytial virus, a ...... s currently in clinical trials
@en
type
label
Respiratory syncytial virus, a ...... s currently in clinical trials
@ast
Respiratory syncytial virus, a ...... s currently in clinical trials
@en
prefLabel
Respiratory syncytial virus, a ...... s currently in clinical trials
@ast
Respiratory syncytial virus, a ...... s currently in clinical trials
@en
P2860
P356
P1476
Respiratory syncytial virus, a ...... s currently in clinical trials
@en
P2093
Helen Groves
Michael D Shields
P2860
P304
P356
10.1111/IRV.12313
P5008
P577
2015-07-01T00:00:00Z